The biotech world is experiencing volatility in the midst of a drug development discontinuation for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) and word from the FDA to …
EndoChoice Holdings Inc EndoChoice Holdings Inc (NYSE:GI) shares jumped nearly 90% today following the news that Boston Scientific Corporation (NYSE:BSX) will acquire GI for $8.00 …
Array BioPharma (NASDAQ:ARRY) shares surged 81% yesterday after the firm conveyed promising phase 3 COLUMBUS results for its BRAF-mutant melanoma cancer treating pipeline …
Jefferies analyst John Janedis provides commentary on shares of Netflix, Inc. (NASDAQ:NFLX) following a proprietary survey that targeted over 1,100 subscribers on the …
Jefferies analysts are diving into the latest biotech news, with Gilead Sciences, Inc. (NASDAQ:GILD) and bluebird bio Inc (NASDAQ:BLUE) on opposite ends of the spectrum.
Jefferies top analyst Mark Lipacis is updating his model for Advanced Micro Devices Inc. (NASDAQ:AMD) amid the company’s recent debt and equity financing.
Jefferies analyst Mike McCormack is out today with a research report on AT&T Inc. (NYSE:T), discussing recent investor concerns regarding the industry movement to unlimited …
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are down nearly 3% to $31.40 in pre-market trading, following a statement from Jefferies’ key opinion leader (KOL) regarding yesterday’s …
Jefferies analyst Brian Abrahams provides insight on shares of Gilead Sciences, Inc. (NASDAQ:GILD) on the heels of hosting a dinner with a leading …
Biogen Inc (NASDAQ:BIIB) indicated in its brief PR update yesterday that its pipeline drug aducanumab, the firm’s investigational treatment for early Alzheimer’s disease …
